News out this morning: Intellia achieves normal #Alpha1 antitrypsin protein levels in non-human primates through targeted gene insertion for the treatment of #AATD. Details here: https://t.co/Nt0vwzVQUW #CRISPR @AlphaFriend https://t.co/FforQfSMg4